Adeno-associated virus serotype 9 antibodies in neonates and young children: Seroprevalence and kinetics.
Saved in:
| Title: | Adeno-associated virus serotype 9 antibodies in neonates and young children: Seroprevalence and kinetics. |
|---|---|
| Authors: | van Olden RW; Novartis Gene Therapies Switzerland GmbH, 6343 Rotkreuz, Switzerland., Lo Bianco C; Novartis Gene Therapies Switzerland GmbH, 6343 Rotkreuz, Switzerland., Dilly KW; Novartis Gene Therapies, Inc., Bannockburn, IL 60015, USA., Savelieva M; Novartis Pharma AG, CH-4056 Basel, Switzerland., Xu S; Novartis Pharmaceuticals, Cambridge, MA 02139, USA., Tijsma A; Cerba Research, Rotterdam 3029, the Netherlands., van Baalen C; Cerba Research, Rotterdam 3029, the Netherlands., Sharma H; Novartis Gene Therapies Switzerland GmbH, 6343 Rotkreuz, Switzerland., Mumneh N; Novartis Pharmaceuticals, East Hanover, NJ 07936, USA. |
| Source: | Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2024 Sep 21; Vol. 32 (4), pp. 101344. Date of Electronic Publication: 2024 Sep 21 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 101624857 Publication Model: eCollection Cited Medium: Print ISSN: 2329-0501 (Print) Linking ISSN: 23290501 NLM ISO Abbreviation: Mol Ther Methods Clin Dev Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2329-0501 |
|---|---|
| DOI: | 10.1016/j.omtm.2024.101344 |
